My 3-month post-IL-2 PET wasn't what I hoped for - three new itty baby nodules in my butt. One option my doctor is suggesting is the OncoVex trial. It's the new phase III trial. 2/3 get OncoVex; 1/3 get subcutaneous GM-CSF in the control arm. I thought of two questions that I didn't ask tonight, and am hoping somebody out there can give me some interim answers while I wait0for Monday to roll around. First, does anybody know if the OncoVex trial has a crossover design? (If I got GM-CSF and progressed, would I get OncoVex?) Second, while I'm aware of the phase III trial results for adjuvant GM-CSF, I'm not immediately aware of any efficacy data for its use in active stage IV disease. I have visited the trial page (http://www.oncovexgmcsf.com/index.html) and the NCI page (http://www.cancer.gov/search/ViewClinicalTrials.aspx?cdrid=617439&version=HealthProfessional&protocolsearchid=8173351) and cannot find the answers. Anybody out there know more?